Haba Laboratories (4925.T) Stock Price
Haba Laboratories Price
Over the last 19 years Haba Laboratories grew revenue by 0.5% annually, reaching 12.14 B JPY. Earnings per share have grown at 1.2% per year over the last 19 years. For Haba Laboratories, the net margin of 6.3% is up versus -2.1% a few years ago. At today's price the dividend yield works out to roughly 4.76%. The payout ratio is around 36% of earnings. The dividend has grown at 7.6% per year over the past 19 years.
Haba Laboratories stock price
Haba Laboratories business model & stock analysis
Frequently asked questions about Haba Laboratories
Converted at the current exchange rate, the Haba Laboratories share trades at 9.47 EUR (1,680.00 JPY).
The revenue of Haba Laboratories is 12.14 B JPY. This figure is based on current financial data and reflects the company's business performance.
The profit of Haba Laboratories is 760.36 M JPY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Haba Laboratories is currently 8.36. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Haba Laboratories stock.
The price-to-sales ratio (P/S) of Haba Laboratories is currently 0.52. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Haba Laboratories stock.
The Eulerpool Quality Score for Haba Laboratories is 2/10.
The ISIN of Haba Laboratories is JP3765130004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Haba Laboratories is 4925.T. The ticker symbol is used to trade Haba Laboratories shares on the stock exchange.
Haba Laboratories stock
Haba Laboratories Peer Group
Haba Laboratories FIGI
All fundamentals and in-depth analysis of Haba Laboratories
Our stock analysis for Haba Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Haba Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.